VC

Vivo Capital Portfolio holdings

AUM $977M
This Quarter Return
+46.63%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$1B
AUM Growth
+$1B
Cap. Flow
-$15.9M
Cap. Flow %
-1.59%
Top 10 Hldgs %
62.05%
Holding
51
New
6
Increased
3
Reduced
11
Closed
2

Top Buys

1
INSM icon
Insmed
INSM
$34M
2
CBAY
Cymabay Therapeutics
CBAY
$15.3M
3
QURE icon
uniQure
QURE
$10.8M
4
KNSA icon
Kiniksa Pharmaceuticals
KNSA
$10.4M
5
DERM
Dermira, Inc.
DERM
$9.49M

Top Sells

1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$67.3M
2
ASND icon
Ascendis Pharma
ASND
$14.1M
3
APLS icon
Apellis Pharmaceuticals
APLS
$9.58M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
$9.49M
5
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
$5.91M

Sector Composition

1 Healthcare 97.66%
2 Materials 1.16%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ASND icon
1
Ascendis Pharma
ASND
$11.8B
$241M 24.02% 2,046,832 -120,000 -6% -$14.1M
CRNX icon
2
Crinetics Pharmaceuticals
CRNX
$2.92B
$76.8M 7.66% 3,375,169 -417,000 -11% -$9.49M
CDXS icon
3
Codexis
CDXS
$246M
$53.8M 5.36% 2,618,951 -95,507 -4% -$1.96M
ARWR icon
4
Arrowhead Research
ARWR
$3.05B
$42.7M 4.26% 2,328,475 – –
KALV icon
5
KalVista Pharmaceuticals
KALV
$678M
$38.9M 3.88% 1,359,149 – –
SVA
6
DELISTED
Sinovac Biotech, Ltd
SVA
$38.2M 3.81% 5,900,000 – –
INSM icon
7
Insmed
INSM
$28.8B
$34M 3.39% +1,170,290 New +$34M
KDMN
8
DELISTED
Kadmon Holdings, Inc.
KDMN
$33.3M 3.32% 12,606,605 +2,152,060 +21% +$5.68M
QTTB icon
9
Q32 Bio
QTTB
$20.9M
$32.2M 3.21% 1,159,742 – –
VYNE icon
10
VYNE Therapeutics
VYNE
$8.16M
$31.5M 3.14% 4,011,236 – –
TCDA
11
DELISTED
Tricida, Inc. Common Stock
TCDA
$29.5M 2.94% 781,185 – –
CBAY
12
DELISTED
Cymabay Therapeutics
CBAY
$27.3M 2.72% 2,056,000 +1,150,000 +127% +$15.3M
BHVN
13
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$26M 2.59% 504,980 -1,308,360 -72% -$67.3M
EIGR
14
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$25M 2.5% 1,791,257 – –
MRTX
15
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$18.4M 1.84% 251,107 – –
MEIP icon
16
MEI Pharma
MEIP
$160M
$17.7M 1.77% 5,778,106 – –
KNSA icon
17
Kiniksa Pharmaceuticals
KNSA
$2.48B
$15.2M 1.52% 843,478 +578,600 +218% +$10.4M
IOVA icon
18
Iovance Biotherapeutics
IOVA
$807M
$15.2M 1.52% 1,600,000 – –
XENE icon
19
Xenon Pharmaceuticals
XENE
$2.98B
$14.3M 1.42% 1,405,476 – –
ACER
20
DELISTED
Acer Therapeutics Inc. Common Stock (DE)
ACER
$14.1M 1.4% 579,051 – –
OBSV
21
DELISTED
ObsEva SA Ordinary Shares
OBSV
$12M 1.2% 937,147 – –
AMRS
22
DELISTED
Amyris Inc.
AMRS
$11.7M 1.16% 5,575,785 – –
QURE icon
23
uniQure
QURE
$896M
$10.8M 1.07% +180,336 New +$10.8M
NBRV
24
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$10.7M 1.07% 4,403,687 -2,215,503 -33% -$5.41M
ZYME icon
25
Zymeworks
ZYME
$1.12B
$10M 1% 620,134 – –
1
2 3